Americans prioritize medication prices

In addition to electing a new president, U.S. voters would like to see the price of prescription drugs come down, according to a survey that the Alliance of Minority Medical Associations has conducted. According to the survey, affordability of medicines is a top priority of 47 percent of respondents. Less than a quarter of respondents said that ease of access to doctors, clinics and hospitals was a second priority for them.

Americans are also supportive of more rapid approvals of generic medications and biotechnology add-ons for current drugs, the survey found.

- see this article from the Pharmaceutical Business Review

Suggested Articles

CEPI, which started to help prepare the world for new outbreaks, has awarded Inovio and Moderna money for vaccine work against the new coronavirus.

The real estate impresario that built a chain of upscale drug recovery facilities is now building a gene and cell therapy CDMO near Philadelphia.

The seven-year Astellas venture served as a model for Amgen's recent $2.7 billion tie-up with BeiGene in China—and now it's amping up there, too.